Wockhardt divests nutrition business

MUMBAI, India — Indian generic drug maker Wockhardt will sell its nutrition business to France's Danone, the company said Tuesday.



The deal is worth $355 million, according to published reports, and includes brands like Farex, Dexolac, Nusobee and Protinex.



Wockhardt said the deal was part of a strategy to consolidate and rationalize its core operations and focus on its pharmaceutical business.